Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laboratory screening. A critical survey.

C C Korvin, R H Pearce

    Canadian Medical Association Journal
    |November 20, 1971
    PubMed
    Summary
    This summary is machine-generated.

    Early disease diagnosis does not guarantee patient benefit or improved outcomes. Evaluating screening requires assessing the practical value of the collected data, not just the diagnosis itself.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The detection and assay of hyaluronidase by means of mucoid streptococci.

    Canadian journal of research. Section E, Medical sciences·2014
    Same author

    Gamma Globulin and Asthma.

    Canadian Medical Association journal·2010
    Same author

    The mucopolysaccharide content of the skin in localized (pretibial) myxedema.

    American journal of clinical pathology·2010
    Same author

    The biochemistry of the skin; a review; with particular reference to the mucopolysaccharides.

    The British journal of dermatology and syphilis·2010
    Same author

    A model of unloaded human intervertebral disk based on NMR relaxation.

    Magnetic resonance in medicine·2000
    Same author

    Non-proteoglycan forms of biglycan increase with age in human articular cartilage.

    The Biochemical journal·1993

    Area of Science:

    • Medical diagnostics
    • Public health screening
    • Evidence-based medicine

    Background:

    • Disease diagnosis is often equated with patient benefit, but this assumption requires scrutiny.
    • The value of early diagnosis in facilitating cure or improving disease control is not always evident.
    • The discovery of predictable or already known information through screening offers limited clinical value.

    Purpose of the Study:

    • To critically evaluate the inherent assumptions linking disease diagnosis to patient benefit.
    • To question the automatic correlation between early diagnosis and improved health outcomes.
    • To establish a framework for assessing the true utility of medical screening programs.

    Main Methods:

    • Literature review of diagnostic and screening methodologies.

    Related Experiment Videos

  • Analysis of clinical outcomes data in relation to diagnostic timing.
  • Conceptual framework development for evaluating screening utility.

    • Main Results:

    • Diagnosis does not automatically equate to patient benefit; clinical utility is paramount.
    • Early detection does not inherently lead to better cure rates or disease management.
    • The value of screening is determined by the usefulness of the data generated, not merely the act of diagnosis.

    Conclusions:

    • Screening programs must be evaluated based on the actionable and beneficial information they provide.
    • The focus should shift from early detection alone to the demonstrable improvement in patient outcomes.
    • Assessing the utility of collected data is crucial for justifying and optimizing medical screening.